Article info
PDFDTB select
Safety update: dupilumab and ocular adverse reactions
Citation
Safety update: dupilumab and ocular adverse reactions
Publication history
- First published December 21, 2022.
Online issue publication
December 21, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.